KAO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.75 EUR | 0.00% |
|
+2.65% | +3.33% |
| Jul. 04 | Japan asset managers back corporate governance push, Oasis founder says | RE |
| Jun. 28 | Activist investor Oasis launches campaign against Japan drug store chain Ain | RE |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Sales forecast by analysts have been recently revised upwards.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- With an expected P/E ratio at 29.46 and 25.66 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Sector: Personal Products
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +3.33% | 19.88B | - | ||
| -8.44% | 241B | B- | ||
| 0.00% | 19.55B | - | - | |
| +10.28% | 11.87B | A- | ||
| -15.94% | 9.01B | A- | ||
| +6.76% | 6.93B | B+ | ||
| +8.20% | 5.85B | B | ||
| -10.12% | 4.14B | C- | ||
| -5.57% | 4.05B | B+ | ||
| -0.28% | 3.81B | B |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 4452 Stock
- KAO0 Stock
- Ratings Kao Corporation
